Peplin: Clinical Trials

5 trials sponsored by Peplin, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

5 completed. 5 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 35Completed 5

Follow Peplin: new trials by email

Trials (filtered) newest first · largest first

All 5 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Multicenter Study to Evaluate the Efficacy and Safety of PEP005 (Ingenol Mebutate) Gel When Used to Treat Actinic Keratoses (AKs) on the Non Head Locations
PEP005 (ingenol mebutate) Gel, Vehicle gel - Actinic Keratoses
Phase 3CompletedPeplin2032009-07-012015-03-06
A Multi-Center Study to Evaluate the Efficacy and Safety of PEP005 (Ingenol Mebutate) Gel, When Used to Treat Actinic Keratoses on the Head (Face or Scalp)
PEP005 (Ingenol Mebutate) gel, 0.015%, Vehicle Gel - Actinic Keratosis
Phase 3CompletedPeplin2782009-06-012015-03-06
A Multi-center Study to Evaluate the Safety and Efficacy of PEP005 (Ingenol Mebutate) Gel, When Used to Treat Actinic Keratoses on Non-head Locations (Trunk and Extremities)
PEP005 Gel - Actinic Keratosis
Phase 3CompletedPeplin1022009-06-012015-04-15
A Multi-center Study to Evaluate the Efficacy and Safety of PEP005 (Ingenol Mebutate) Gel, When Used to Treat Actinic Keratoses on the Head (Face or Scalp)
PEP005 Gel, Vehicle gel - Actinic Keratosis
Phase 3CompletedPeplin2692009-06-012015-04-02
A Multicenter Study to Evaluate the Efficacy and Safety of PEP005 (Ingenol Mebutate) Gel When Used to Treat Actinic Keratoses (AKs) on the Non Head Locations
PEP005 (ingenol mebutate) Gel, Vehicle gel - Actinic Keratoses
Phase 3CompletedPeplin2552008-09-012015-03-06

Conditions studied

Keratosis, Actinic (5)

Interventions

3-ingenyl angelate (5)  ·  Gels (3)

Countries

United States (5)  ·  Australia (4)

Top investigators

Eugene Bauer, MD (2)

Results publications

PMID 22417254